COMMON STOCK |
9 Months Ended |
|---|---|
Apr. 30, 2025 | |
| Equity [Abstract] | |
| COMMON STOCK | NOTE 7 - COMMON STOCK
On April 30, 2025 and July 31, 2024, we had and shares of common stock outstanding, respectively. We issued unregistered shares of our common stock, of which shares were issued for cash, shares for a loan modification fee, shares were issued for the payment of accrued expenses, were issued for conversion of debt and related accrued interest, shares were issued for services and were issued for compensation during the nine months ended April 30, 2025. During the fiscal year ended July 31, 2024, we issued unregistered shares of our common stock, of which shares were issued for cash, shares were issued for the payment of accrued expenses, were issued for compensation, shares were issued for services, and shares were issued for a loan modification fee.
On August 25, 2024, we issued unregistered shares of our common stock to a member of our Board of Directors as compensation for serving on the Board and for providing certain other business advisory services. The shares were issued upon the vesting of shares from a restricted stock award dated August 25, 2024 at an estimated grant date fair value of $ per share on such date.
On September 1, 2024, we issued unregistered shares of our common stock to a consultant pursuant to the terms of a consulting agreement. The shares were issued upon the vesting of shares from a restricted stock award dated September 1, 2024, at an estimated grant date fair value of $ per share on such date.
On September 20, 2024, we completed a private placement of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $100,000. We incurred no cost related to the private placement.
On September 26, 2024, we completed a private placement of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $100,000. We incurred no cost related to the private placement.
On October 8, 2024, we completed multiple private placements of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $200,000. We incurred no cost related to the private placements.
On October 10, 2024, we completed multiple private placements of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $350,000. We incurred no cost related to the private placements.
On October 18, 2024, we completed a private placement of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $100,000. We incurred no cost related to the private placement.
On October 19, 2024, we issued shares of common stock to a consultant pursuant to the terms of a consulting agreement entered on October 19, 2022. The shares were issued to the consultant at an estimated value of $ per share.
On October 19, 2024, we issued shares of common stock to consultants pursuant to the terms of their consulting agreements entered on October 19, 2022. These shares were issued to the consultants at an estimated value of $ per share.
On October 21, 2024, we completed multiple private placements of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $100,000. We incurred no cost related to the private placements.
On October 22, 2024, we completed multiple private placements of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $200,000. We incurred no cost related to the private placements.
On October 24, 2024, we completed multiple private placements of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $230,000. We incurred no cost related to the private placements.
On October 25, 2024, we completed multiple private placements of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $652,000. We incurred no cost related to the private placements.
On October 25, 2024, we issued unregistered shares of our common stock for settlement of accounts payables. The shares were issued at an agreed upon value of $per share.
On October 29, 2024, we completed a private placement of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $100,000. We incurred no cost related to the private placement.
On October 29, 2024, we issued unregistered shares of our common stock to the Chief Strategy Officer. The shares were issued to the officer at an estimated grant date fair value of $ per share.
On October 31, 2024, we completed a private placement of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $100,000. We incurred no cost related to the private placement.
On November 1, 2024, we completed a private placement of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $100,000. We incurred no cost related to the private placement.
On November 5, 2024, we completed a private placement of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $100,000. We incurred no cost related to the private placement.
On November 6, 2024, we completed a private placement of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $20,000. We incurred no cost related to the private placement.
On November 11, 2024, we completed a private placement of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $200,000. We incurred no cost related to the private placement.
On November 13, 2024, we issued shares of common stock to a previous lender pursuant to a make-whole provision included as part of a loan modification fee. The shares were issued at an estimated value of $ per share.
On November 19, 2024, we issued unregistered shares of our common stock for settlement of accounts payables. The shares were issued at an agreed upon value of $ per share.
On December 1, 2024, we issued shares of common stock to a consultant pursuant to the terms of their consulting agreement. The shares were issued to the consultants at an estimated value of $ per share.
On December 1, 2024, we issued unregistered shares of our common stock to the Chief Financial Officer. The shares were issued to the officer at an estimated grant date fair value of $ per share.
On December 5, 2024, we issued shares of common stock to a consultant pursuant to the terms of their consulting agreement. The shares were issued to the consultants at an estimated value of $ per share.
On December 20, 2024, we issued unregistered shares of our common stock to a member of our Board of Directors as compensation for serving on the Board at their resignation. The shares were issued as part of a settlement agreement at an estimated grant date at a fair value of $ per share.
On January 1, 2025, we issued shares of common stock to consultants pursuant to the terms of their consulting agreement. The shares were issued to the consultants at an estimated value of $ per share.
On January 2, 2025, we issued shares of common stock to consultants pursuant to the terms of their consulting agreement. The shares were issued to the consultants at an estimated value of $ per share.
On January 6, 2025, we completed a private placement of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $100,000. We incurred no cost related to the private placement.
On January 15, 2025, we completed a private placement of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $100,000. We incurred no cost related to the private placement.
On January 20, 2025, we issued shares of common stock to consultants pursuant to the terms of their consulting agreement. The shares were issued to the consultants at an estimated value of $ per share.
On January 24, 2025, we completed a private placement of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $100,000. We incurred no cost related to the private placement.
On January 26, 2025, we completed multiple private placements of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $590,200. We incurred no cost related to the private placements.
On January 27, 2025, we completed multiple private placements of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $326,000. We incurred no cost related to the private placements.
On January 28, 2025, we completed multiple private placements of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $856,000. We incurred no cost related to the private placements.
On January 29, 2025, we completed multiple private placements of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $1,221,900. We incurred no cost related to the private placements.
On January 30, 2025, we completed multiple private placements of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $552,000. We incurred no cost related to the private placements.
On January 31, 2025, we completed multiple private placements of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $500,800. We incurred no cost related to the private placements.
On February 3, 2025, we completed multiple private placements of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $562,000. We incurred no cost related to the private transaction.
On February 4, 2025, we completed a private placement of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $100,000. We incurred no cost related to the private transaction.
On February 5, 2025, we completed a private placement of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $378,000. We incurred no cost related to the private transaction.
On February 6, 2025, we completed multiple private placements of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $426,800. We incurred no cost related to the private transaction.
On February 7, 2025, we completed multiple private placements of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $400,000. We incurred no cost related to the private transaction.
On February 10, 2025, we completed multiple private placements of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $226,000. We incurred no cost related to the private transaction.
On February 11, 2025, we completed a private placement of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $110,000. We incurred no cost related to the private transaction.
On February 12, 2025, we completed a private placement of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $50,000. We incurred no cost related to the private transaction.
On February 14, 2025, we issued shares of common stock to multiple consultants pursuant to the terms of their consulting agreements. These shares were issued to the consultants at an estimated value of $ per share.
On February 18, 2025, we completed multiple private placements of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $283,000. We incurred no cost related to the private transaction.
On February 20, 2025, we completed a private placement of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $100,000. We incurred no cost related to the private transaction.
On February 21, 2025, we completed a private placement of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $100,000. We incurred no cost related to the private transaction.
On February 26, 2025, we completed a private placement of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $175,000. We incurred no cost related to the private transaction.
On February 26, 2025, we issued shares of common stock to a previous lender pursuant to a make-whole provision included as part of a loan modification fee. The shares were issued at an estimated value of $ per share.
On February 27, 2025, we completed a private placement of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $126,000. We incurred no cost related to the private transaction.
On March 1, 2025, we issued shares of common stock to a consultant pursuant to the terms of their consulting agreements. These shares were issued to the consultants at an estimated value of $ per share.
On March 21, 2025, we completed a private placement of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $125,000. We incurred no cost related to the private transaction.
On March 21, 2025, we issued shares of common stock to multiple holders of our 5% Convertible Promissory Notes in exchange for the Note plus accrued interest through the conversion date. Under the terms of the Note, the shares were issued at a conversion price of $0.50 per share.
On March 25, 2025, we issued shares of common stock to multiple holders of our 5% Convertible Promissory Notes in exchange for the Note plus accrued interest through the conversion date. Under the terms of the Note, the shares were issued at a conversion price of $0.50 per share.
On March 26, 2025, we issued shares of common stock to multiple holders of our 5% Convertible Promissory Notes in exchange for the Note plus accrued interest through the conversion date. Under the terms of the Note, the shares were issued at a conversion price of $0.50 per share.
On April 1, 2025, we issued unregistered shares of our common stock to a consultant pursuant to the terms of a consulting agreement at an estimated grant date fair value of $ per share on such date.
On April 5, 2025, we issued shares of common stock to multiple holders of our 5% Convertible Promissory Notes in exchange for the Note plus accrued interest through the conversion date. Under the terms of the Note, the shares were issued at a conversion price of $0.50 per share.
On April 14, 2025, we completed a private placement of unregistered shares of our common stock at a price of $ per share resulting in net proceeds to the Company of $100,000. We incurred no cost related to the private transaction.
On April 17, 2025, we issued unregistered shares of our common stock to the Chief Revenue Officer. The shares were issued to the officer at an estimated grant date fair value of $ per share.
On April 24, 2025, we issued unregistered shares of our common stock to a member of our Board of Directors as compensation for serving on the Board and for providing certain other business advisory services at an estimated grant date fair value of $ per share.
|